Developer docs
API playgroundTry for free, no card

Search company profiles

Viromii

Full company profile

uuid000imp7

Namestring
Viromii
Legal namestring
VIROMII INNOVATION.S.L.
Websiteurl
viromii.com
Company typeenum
Private
Founded yearint
2017
Descriptiontext

Viromii is a Valencia-headquartered consulting firm, founded in 2017 and operating as a Spanish Sociedad Limitada (VIROMII INNOVATION.S.L.), that specializes in research valorization and technology transfer for the R&D ecosystem. Its core offering is a portfolio of professional services — research valorization, technology transfer, regulatory roadmaps, training, business plans for spin-offs, market research, business development support, and investor matchmaking — delivered to universities, public research centers, technology-based spin-offs and startups, high-tech companies, and investors. The firm differentiates on a tailored, end-to-end engagement model (it accompanies clients throughout the project rather than delivering a report and disengaging) and on proprietary databases and methods used to identify commercialization pathways for research outputs.

The company has a small operating footprint of 1-10 employees and is founder-owned and bootstrapped, with no disclosed equity funding rounds, institutional investors, or M&A activity. Its customer base is concentrated in the Spanish public research sector, with named engagements including Universitat Politècnica de València (UPV), CSIC, INCLIVA, Hospital General Universitario de Valencia, and Instituto Maimónides de Investigación Biomédica de Córdoba, and includes international logos such as the University of Gothenburg. A landmark commercial outcome was the licensing of a patented dsRNA production method developed by IBMCP (UPV-CSIC) to a leading US biotechnology company in 2020-2021. The most recent strategic move is participation in the BIOVALSA consortium with AIMPLAS and partners (announced January 2026), funded by IVACE+i and ERDF, targeting sustainable bioplastics from agricultural waste.

Viromii's go-to-market is sales-led direct B2B consulting, supported by content marketing (company website, blog, email) and professional networking on LinkedIn. Pricing is quote-based and tailored to each engagement, with no publicly disclosed rates or standard pricing model. Geographic reach is described as international, with partners, clients, and team members distributed globally, though no formal offices outside Valencia are disclosed. Revenue figures are not publicly reported, and the firm does not appear to operate a software product, app, API, or AI/ML capability that would alter its classification as a traditional professional services intermediary.

Short descriptiontext

Viromii is a Valencia, Spain-based consulting firm founded in 2017 that provides research valorization, technology transfer, and business development services to universities, research centers, spin-offs, startups, and investors.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersValencia, Spain
HQ citystring
Valencia
HQ countrystring
Spain
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
technology transfer consulting, research valorization services, innovation commercialization consulting, biotech business development, investor matchmaking services
Industry1 code
PRIMARYFSANAHAL
Corporate Deep Tech / R&D Commercialization CVC
NAICS code1 code
  • Other Scientific and Technical Consulting Services54169
SIC code1 code
  • Services-Management Consulting Services8742
Product category
Technology Transfer Consulting
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Consulting Services Revenue
TypeProfessional Services
Description

Professional consulting services for research valorization, technology transfer, regulatory roadmaps, training, business plans, market research, and business development support for R&D institutions and tech companies.

viromii.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Marketing or Sales, Technology or R&D, Others
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Viromii is a consulting firm that helps R&D institutions, universities, spin-offs, startups, and high-tech companies bring research innovations to market. It delivers tailored research valorization, technology transfer, regulatory roadmap, training, business plan, market research, and business development services, complemented by investor matchmaking, using proprietary databases and methods.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Viromii is a consulting firm focused on innovation and technology transfer, supporting R&D institutions and tech-companies. The company offers a portfolio of professional services including Research Valorization, Technology Transfer, Regulatory Roadmaps, and Training for R&D institutions, as well as Business Plans for Spin-offs, Market Research and Evaluations, and Business Development Support for spin-offs and startups. The firm works with universities, research centres, high-tech companies and investors worldwide to help bring innovations to market.

Product and service8 records
1Research Valorization
CategoryConsulting / Technology Transfer
Description

Service helping R&D institutions transform research outcomes into commercially viable opportunities. Targeted at universities, research centres, and public R&D bodies.

2Technology Transfer
CategoryConsulting / Technology Transfer
Description

Service facilitating the movement of innovations from research institutions to commercial applications, including licensing of technologies to companies.

3Regulatory Roadmaps
CategoryConsulting / Regulatory
Description

Service guiding R&D institutions and tech companies through compliance and regulatory requirements for bringing innovations to market.

4Training
CategoryConsulting / Training
Description

Training programs for R&D institutions on innovation and technology transfer processes.

5Business Plans for Spin-offs
CategoryConsulting / Strategy
Description

Business plan development service for spin-offs and startups emerging from research institutions, supporting market entry and growth.

6Market Research and Evaluations
CategoryConsulting / Market Intelligence
Description

Market research and evaluation services for spin-offs and startups to assess commercial potential and validate opportunities.

7Business Development Support
CategoryConsulting / Business Development
Description

Ongoing business development support provided throughout client projects, accompanying clients beyond a report deliverable.

8Investor Matchmaking
CategoryConsulting / Matchmaking
Description

Investor matchmaking service connecting startups and spin-offs with potential investors across biotech, cleantech, agrotech, and other high-impact sectors.

Scale indicator1 record

Each record includes

Type, Value, Description, Source

Partnership7 partners
1AIMPLAS
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-01-08
Description

AIMPLAS (Plastics Technology Centre) coordinates the BIOVALSA project for sustainable bioplastics from agricultural waste. Viromii participates as a partner in this R&D collaboration funded by IVACE+i and ERDF funds, contributing to research valorization and technology transfer activities.

azom.com
Strategic tierMinorTypeStrategic or Co-development Partner
Description

FoodUPV is a partner in the BIOVALSA project consortium, contributing to the development of innovative processes for manufacturing sustainable bioplastics from agricultural waste.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Bioban is a partner in the BIOVALSA project consortium focused on converting agricultural waste into sustainable bioplastics.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Prime Biopolymers is a partner in the BIOVALSA project consortium working on bioplastic manufacturing from agricultural residues.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Viromii collaborated with the Research, Innovation and Transfer Promotion and Support Service (I2T) of UPV to drive technology transfer of dsRNA production method. I2T is UPV's technology transfer office.

Strategic tierCoreTypeTechnology or Integration
Description

IBMCP (UPV-CSIC joint institute) developed the patented dsRNA production technology that Viromii helped commercialize, successfully licensing it to a US biotechnology company.

7Various Universities and Research Institutions
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Viromii works with universities, research centres, and prominent institutions from all over the world as clients and partners in technology transfer projects.

viromii.com
Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Open-innovation and technology-transfer consultancy with offices in San Francisco and Europe; directly comparable for cross-border R&D commercialization mandates and corporate-startup bridge programs.

TypeDirect peer
Description

Oxford University spin-out technology-transfer and innovation consultancy; highly comparable in service mix (valorization, licensing support, spin-out advisory) for research institutions worldwide.

3PNO Innovation
TypeDirect peer
Description

European innovation and R&D grants consultancy supporting consortia like Horizon Europe; directly comparable on R&D valorization, partnership building, and EU-funded project participation.

4Biocat
TypeRegional player
Description

Catalan biotech and health innovation ecosystem organization that runs valorization and acceleration programs; comparable for biotech-focused research-to-market activities, but region-specific (Catalonia).

TypeDirect peer
Description

Global innovation marketplace and technology-transfer platform connecting research organizations with industry and investors; competitive overlap in open innovation, matchmaking, and tech-transfer services.

TypeDirect peer
Description

European life-sciences and health innovation consultancy supporting commercialization of academic research; comparable in fund/grant acquisition and spin-out support across academic clients.

TypeDirect peer
Description

European grants and innovation funding consultancy operating across EU member states; overlapping services in EU funding capture and R&D program support.

TypeBroad incumbent
Description

Large Catalan technology center providing applied R&D and innovation services; comparable for technology-transfer and research valorization work but at a much wider scope and scale.

TypeBroad incumbent
Description

Barcelona-based healthcare and life-sciences venture capital firm that also supports spin-outs and academic commercialization; relevant adjacent player for biotech investor matchmaking.

10CDTI (Centro para el Desarrollo Tecnológico e Industrial)
TypeRegional player
Description

Spanish public R&D and innovation funding agency that funds and supports technology-transfer projects; direct overlap on Spanish R&D valorization mandates and EU-funding advisory.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers5 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature1 record

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Viromii

Technology Transfer Consultingviromii.com

Viromii is a Valencia, Spain-based consulting firm founded in 2017 that provides research valorization, technology transfer, and business development services to universities, research centers, spin-offs, startups, and investors.

What Viromii does

Viromii is a Valencia-headquartered consulting firm, founded in 2017 and operating as a Spanish Sociedad Limitada (VIROMII INNOVATION.S.L.), that specializes in research valorization and technology transfer for the R&D ecosystem. Its core offering is a portfolio of professional services — research valorization, technology transfer, regulatory roadmaps, training, business plans for spin-offs, market research, business development support, and investor matchmaking — delivered to universities, public research centers, technology-based spin-offs and startups, high-tech companies, and investors. The firm differentiates on a tailored, end-to-end engagement model (it accompanies clients throughout the project rather than delivering a report and disengaging) and on proprietary databases and methods used to identify commercialization pathways for research outputs.

The company has a small operating footprint of 1-10 employees and is founder-owned and bootstrapped, with no disclosed equity funding rounds, institutional investors, or M&A activity. Its customer base is concentrated in the Spanish public research sector, with named engagements including Universitat Politècnica de València (UPV), CSIC, INCLIVA, Hospital General Universitario de Valencia, and Instituto Maimónides de Investigación Biomédica de Córdoba, and includes international logos such as the University of Gothenburg. A landmark commercial outcome was the licensing of a patented dsRNA production method developed by IBMCP (UPV-CSIC) to a leading US biotechnology company in 2020-2021. The most recent strategic move is participation in the BIOVALSA consortium with AIMPLAS and partners (announced January 2026), funded by IVACE+i and ERDF, targeting sustainable bioplastics from agricultural waste.

Viromii's go-to-market is sales-led direct B2B consulting, supported by content marketing (company website, blog, email) and professional networking on LinkedIn. Pricing is quote-based and tailored to each engagement, with no publicly disclosed rates or standard pricing model. Geographic reach is described as international, with partners, clients, and team members distributed globally, though no formal offices outside Valencia are disclosed. Revenue figures are not publicly reported, and the firm does not appear to operate a software product, app, API, or AI/ML capability that would alter its classification as a traditional professional services intermediary.

Viromii firmographics

Firmographics
Name
Viromii
Legal name
VIROMII INNOVATION.S.L.
Website
https://viromii.com
Company type
Private
Founded year
2017
Operating status
Operating
Headcount range
11–50 employees
Short description
Viromii is a Valencia, Spain-based consulting firm founded in 2017 that provides research valorization, technology transfer, and business development services to universities, research centers, spin-offs, startups, and investors.
Ownership category
akta.pro rank

Viromii industry classification

Industry
Product category
Technology Transfer Consulting
NAICS
Other Scientific and Technical Consulting Services (54169)
SIC
Services-Management Consulting Services (8742)
akta.pro industry
PRIMARYFSANAHAL
Corporate Deep Tech / R&D Commercialization CVC

Keywords

  • Technology transfer consulting
  • Research valorization services
  • Innovation commercialization consulting
  • Biotech business development
  • Investor matchmaking services

Where Viromii is headquartered

Location

Headquarters

HQ city
Valencia
HQ country
Spain
HQ region
Europe

Offices1 record

Markets served

Viromii business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Technology or R&D, Others

Revenue model

  1. Consulting Services Revenue: Professional consulting services for research valorization, technology transfer, regulatory roadmaps, training, business plans, market research, and business development support for R&D institutions and tech companies.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Viromii product offering

Product offering

Core offering

Viromii is a consulting firm that helps R&D institutions, universities, spin-offs, startups, and high-tech companies bring research innovations to market. It delivers tailored research valorization, technology transfer, regulatory roadmap, training, business plan, market research, and business development services, complemented by investor matchmaking, using proprietary databases and methods.

Product overview

Viromii is a consulting firm focused on innovation and technology transfer, supporting R&D institutions and tech-companies. The company offers a portfolio of professional services including Research Valorization, Technology Transfer, Regulatory Roadmaps, and Training for R&D institutions, as well as Business Plans for Spin-offs, Market Research and Evaluations, and Business Development Support for spin-offs and startups. The firm works with universities, research centres, high-tech companies and investors worldwide to help bring innovations to market.

Differentiator

Problem solved

Functional benefit

Products and services

  • Research Valorization Service helping R&D institutions transform research outcomes into commercially viable opportunities. Targeted at universities, research centres, and public R&D bodies.
  • Technology Transfer Service facilitating the movement of innovations from research institutions to commercial applications, including licensing of technologies to companies.
  • Regulatory Roadmaps Service guiding R&D institutions and tech companies through compliance and regulatory requirements for bringing innovations to market.
  • Training Training programs for R&D institutions on innovation and technology transfer processes.
  • Business Plans for Spin-offs Business plan development service for spin-offs and startups emerging from research institutions, supporting market entry and growth.
  • Market Research and Evaluations Market research and evaluation services for spin-offs and startups to assess commercial potential and validate opportunities.
  • Business Development Support Ongoing business development support provided throughout client projects, accompanying clients beyond a report deliverable.
  • Investor Matchmaking Investor matchmaking service connecting startups and spin-offs with potential investors across biotech, cleantech, agrotech, and other high-impact sectors.

Companies that use Viromii

Customer profile

Named customers5 records

Segments4 records

Ideal customer profiles4 records

Viromii technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature1 record

Viromii partnerships and signals

Strategic signal

Partnerships

Seven partnerships are on record, tiered core and minor.

  • AIMPLAScoreStrategic or Co-development Partner · 8 January 2026AIMPLAS (Plastics Technology Centre) coordinates the BIOVALSA project for sustainable bioplastics from agricultural waste. Viromii participates as a partner in this R&D collaboration funded by IVACE+i and ERDF funds, contributing to research valorization and technology transfer activities.
  • FoodUPVminorStrategic or Co-development PartnerFoodUPV is a partner in the BIOVALSA project consortium, contributing to the development of innovative processes for manufacturing sustainable bioplastics from agricultural waste.
  • BiobanminorStrategic or Co-development PartnerBioban is a partner in the BIOVALSA project consortium focused on converting agricultural waste into sustainable bioplastics.
  • Prime BiopolymersminorStrategic or Co-development PartnerPrime Biopolymers is a partner in the BIOVALSA project consortium working on bioplastic manufacturing from agricultural residues.
  • Universitat Politècnica de València (UPV) - I2TcoreStrategic or Co-development PartnerViromii collaborated with the Research, Innovation and Transfer Promotion and Support Service (I2T) of UPV to drive technology transfer of dsRNA production method. I2T is UPV's technology transfer office.
  • Instituto de Biología Molecular y Celular de Plantas (IBMCP)coreTechnology or IntegrationIBMCP (UPV-CSIC joint institute) developed the patented dsRNA production technology that Viromii helped commercialize, successfully licensing it to a US biotechnology company.
  • Various Universities and Research InstitutionscoreStrategic or Co-development PartnerViromii works with universities, research centres, and prominent institutions from all over the world as clients and partners in technology transfer projects.

Scale indicators1 record

Recent moves5 records

Expansion highlights4 records

Viromii competitors and assessment

Company assessment

Direct peers

  • Mind the Bridge: Open-innovation and technology-transfer consultancy with offices in San Francisco and Europe; directly comparable for cross-border R&D commercialization mandates and corporate-startup bridge programs.
  • Oxentia: Oxford University spin-out technology-transfer and innovation consultancy; highly comparable in service mix (valorization, licensing support, spin-out advisory) for research institutions worldwide.
  • PNO Innovation: European innovation and R&D grants consultancy supporting consortia like Horizon Europe; directly comparable on R&D valorization, partnership building, and EU-funded project participation.
  • Innoget: Global innovation marketplace and technology-transfer platform connecting research organizations with industry and investors; competitive overlap in open innovation, matchmaking, and tech-transfer services.
  • Catalyze: European life-sciences and health innovation consultancy supporting commercialization of academic research; comparable in fund/grant acquisition and spin-out support across academic clients.
  • FundingBox: European grants and innovation funding consultancy operating across EU member states; overlapping services in EU funding capture and R&D program support.

Regional players

  • Biocat: Catalan biotech and health innovation ecosystem organization that runs valorization and acceleration programs; comparable for biotech-focused research-to-market activities, but region-specific (Catalonia).
  • CDTI (Centro para el Desarrollo Tecnológico e Industrial): Spanish public R&D and innovation funding agency that funds and supports technology-transfer projects; direct overlap on Spanish R&D valorization mandates and EU-funding advisory.

Broad incumbents

  • Eurecat: Large Catalan technology center providing applied R&D and innovation services; comparable for technology-transfer and research valorization work but at a much wider scope and scale.
  • Asabys Partners: Barcelona-based healthcare and life-sciences venture capital firm that also supports spin-outs and academic commercialization; relevant adjacent player for biotech investor matchmaking.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

Viromii social profiles

Digital presence

Viromii financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Viromii leadership team

Management profile

Number of profiles

Profiles1 record

Viromii funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Viromii M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Viromii

What does Viromii do?

Viromii is a consulting firm that helps R&D institutions, universities, spin-offs, startups, and high-tech companies bring research innovations to market. It delivers tailored research valorization, technology transfer, regulatory roadmap, training, business plan, market research, and business development services, complemented by investor matchmaking, using proprietary databases and methods.

Is Viromii a public or private company?

Viromii is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Viromii founded?

Viromii was founded in 2017. It employs 11 to 50 people.

Where is Viromii based?

Viromii is headquartered in Valencia, Spain, in the Europe region.

How does Viromii make money?

One revenue line is on record: consulting Services Revenue.

Who are Viromii's main competitors?

Direct peers on record are Mind the Bridge, Oxentia, PNO Innovation, Innoget, Catalyze and FundingBox. Regional players are Biocat and CDTI (Centro para el Desarrollo Tecnológico e Industrial). Broad incumbents are Eurecat and Asabys Partners.

Does Viromii have an API?

No public API is recorded for Viromii.

What industry is Viromii in?

Viromii's product category is Technology Transfer Consulting. Its primary akta.pro industry code is FSANAHAL, Corporate Deep Tech / R&D Commercialization CVC. Its NAICS code is 54169 and its SIC code is 8742.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
AZoMA Project Develops Innovate Processes to Manufacture Sustainable Bioplastics from Agricultural Waste and Pruning ResiduesThe BIOVALSA project, coordinated by AIMPLAS and funded by IVACE+i and ERDF funds, aims to develop innovative and cost-effective processes for manufacturing sustainable bioplastics from agricultural waste such as rice straw and citrus pruning residues generated in the Valencian Community. The project seeks to reduce production costs that currently account for up to 40% of bioplastic manufacturing by developing alternative biological treatments to replace costly commercial enzymes. The process will recover three lignocellulosic fractions—cellulose for PLA, hemicellulose for PBS, and lignin as an antimicrobial additive—and involves collaboration with FoodUPV, Bioban, Viromii, and Prime Biopolymers.Packaging WorldBIOVALSA Project Turns Agricultural Waste and Pruning Residues into Sustainable BioplasticsAIMPLAS, the Plastics Technology Centre, is leading the BIOVALSA project to develop innovative processes for converting agricultural waste such as rice straw and citrus pruning residues into sustainable bioplastics, addressing the high cost barrier where commercial enzymes currently represent up to 40% of processing costs. The initiative involves partner organizations Bioban, Viromii, Prime Biopolymers, and FoodUPV, and aims to separate lignocellulosic biomass into cellulose for lactic acid (PLA production), hemicellulose for succinic acid (PBS production), and lignin for antimicrobial additives. The project is in its first year of development and is funded by IVACE+i and ERDF funds through the Valencian Community's Smart Specialisation Strategy for 2021-2027.